nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.155	0.211	CbGbCtD
Sulfadiazine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.134	0.184	CbGbCtD
Sulfadiazine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0937	0.128	CbGbCtD
Sulfadiazine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0757	0.103	CbGbCtD
Sulfadiazine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0586	0.0801	CbGbCtD
Sulfadiazine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0565	0.0773	CbGbCtD
Sulfadiazine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0545	0.0745	CbGbCtD
Sulfadiazine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0401	0.0548	CbGbCtD
Sulfadiazine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.025	0.0342	CbGbCtD
Sulfadiazine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0229	0.0313	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0156	0.0214	CbGbCtD
Sulfadiazine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000725	0.00271	CcSEcCtD
Sulfadiazine—Stomatitis—Cisplatin—peripheral nervous system neoplasm	0.000725	0.00271	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000719	0.00268	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000719	0.00268	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00071	0.00265	CcSEcCtD
Sulfadiazine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000706	0.00263	CcSEcCtD
Sulfadiazine—Chills—Alitretinoin—peripheral nervous system neoplasm	0.000703	0.00262	CcSEcCtD
Sulfadiazine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.0007	0.00261	CcSEcCtD
Sulfadiazine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.0007	0.00261	CcSEcCtD
Sulfadiazine—Skin discolouration—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.00261	CcSEcCtD
Sulfadiazine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000691	0.00258	CcSEcCtD
Sulfadiazine—Oliguria—Doxorubicin—peripheral nervous system neoplasm	0.000686	0.00256	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000676	0.00252	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000675	0.00252	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000669	0.0025	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000669	0.0025	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.000668	0.00249	CcSEcCtD
Sulfadiazine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000665	0.00248	CcSEcCtD
Sulfadiazine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000665	0.00248	CcSEcCtD
Sulfadiazine—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.000664	0.00248	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000661	0.00247	CcSEcCtD
Sulfadiazine—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000659	0.00246	CcSEcCtD
Sulfadiazine—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.000652	0.00243	CcSEcCtD
Sulfadiazine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000644	0.0024	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.000641	0.00239	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00064	0.00239	CcSEcCtD
Sulfadiazine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000639	0.00238	CcSEcCtD
Sulfadiazine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000639	0.00238	CcSEcCtD
Sulfadiazine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000636	0.00237	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000634	0.00237	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000634	0.00237	CcSEcCtD
Sulfadiazine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000631	0.00235	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000626	0.00234	CcSEcCtD
Sulfadiazine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000623	0.00232	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000606	0.00226	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.000603	0.00225	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000601	0.00224	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000601	0.00224	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.00221	CcSEcCtD
Sulfadiazine—Sepsis—Epirubicin—peripheral nervous system neoplasm	0.000593	0.00221	CcSEcCtD
Sulfadiazine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000591	0.00221	CcSEcCtD
Sulfadiazine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000591	0.0022	CcSEcCtD
Sulfadiazine—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000589	0.0022	CcSEcCtD
Sulfadiazine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000588	0.0022	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000588	0.00219	CcSEcCtD
Sulfadiazine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000586	0.00219	CcSEcCtD
Sulfadiazine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000586	0.00219	CcSEcCtD
Sulfadiazine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000584	0.00218	CcSEcCtD
Sulfadiazine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000584	0.00218	CcSEcCtD
Sulfadiazine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000581	0.00217	CcSEcCtD
Sulfadiazine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000581	0.00217	CcSEcCtD
Sulfadiazine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000581	0.00217	CcSEcCtD
Sulfadiazine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000581	0.00217	CcSEcCtD
Sulfadiazine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000581	0.00217	CcSEcCtD
Sulfadiazine—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000579	0.00216	CcSEcCtD
Sulfadiazine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000576	0.00215	CcSEcCtD
Sulfadiazine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000573	0.00214	CcSEcCtD
Sulfadiazine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00057	0.00213	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000557	0.00208	CcSEcCtD
Sulfadiazine—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000554	0.00207	CcSEcCtD
Sulfadiazine—Chills—Etoposide—peripheral nervous system neoplasm	0.000549	0.00205	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.00205	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000547	0.00204	CcSEcCtD
Sulfadiazine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000546	0.00204	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000545	0.00203	CcSEcCtD
Sulfadiazine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000541	0.00202	CcSEcCtD
Sulfadiazine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000541	0.00202	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000537	0.002	CcSEcCtD
Sulfadiazine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000534	0.00199	CcSEcCtD
Sulfadiazine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000531	0.00198	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000525	0.00196	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000525	0.00196	CcSEcCtD
Sulfadiazine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000524	0.00196	CcSEcCtD
Sulfadiazine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000522	0.00195	CcSEcCtD
Sulfadiazine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00052	0.00194	CcSEcCtD
Sulfadiazine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00052	0.00194	CcSEcCtD
Sulfadiazine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00052	0.00194	CcSEcCtD
Sulfadiazine—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000514	0.00192	CcSEcCtD
Sulfadiazine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000513	0.00191	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.00191	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000512	0.00191	CcSEcCtD
Sulfadiazine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000512	0.00191	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000508	0.0019	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000507	0.00189	CcSEcCtD
Sulfadiazine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000507	0.00189	CcSEcCtD
Sulfadiazine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000504	0.00188	CcSEcCtD
Sulfadiazine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000504	0.00188	CcSEcCtD
Sulfadiazine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000503	0.00188	CcSEcCtD
Sulfadiazine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000503	0.00188	CcSEcCtD
Sulfadiazine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000496	0.00185	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000491	0.00183	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000489	0.00182	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.00181	CcSEcCtD
Sulfadiazine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000485	0.00181	CcSEcCtD
Sulfadiazine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000484	0.00181	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.00179	CcSEcCtD
Sulfadiazine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000479	0.00179	CcSEcCtD
Sulfadiazine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000477	0.00178	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.00178	CcSEcCtD
Sulfadiazine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000475	0.00177	CcSEcCtD
Sulfadiazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000475	0.00177	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000475	0.00177	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.00177	CcSEcCtD
Sulfadiazine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000471	0.00176	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00175	CcSEcCtD
Sulfadiazine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000467	0.00174	CcSEcCtD
Sulfadiazine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000467	0.00174	CcSEcCtD
Sulfadiazine—Rash—Topotecan—peripheral nervous system neoplasm	0.000467	0.00174	CcSEcCtD
Sulfadiazine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000467	0.00174	CcSEcCtD
Sulfadiazine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000466	0.00174	CcSEcCtD
Sulfadiazine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000466	0.00174	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000465	0.00173	CcSEcCtD
Sulfadiazine—Headache—Topotecan—peripheral nervous system neoplasm	0.000464	0.00173	CcSEcCtD
Sulfadiazine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000463	0.00173	CcSEcCtD
Sulfadiazine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000463	0.00173	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000463	0.00173	CcSEcCtD
Sulfadiazine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000463	0.00173	CcSEcCtD
Sulfadiazine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000463	0.00173	CcSEcCtD
Sulfadiazine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000461	0.00172	CcSEcCtD
Sulfadiazine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000461	0.00172	CcSEcCtD
Sulfadiazine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00046	0.00172	CcSEcCtD
Sulfadiazine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00046	0.00172	CcSEcCtD
Sulfadiazine—Rash—Melphalan—peripheral nervous system neoplasm	0.000457	0.00171	CcSEcCtD
Sulfadiazine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000457	0.0017	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000455	0.0017	CcSEcCtD
Sulfadiazine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000452	0.00169	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000446	0.00167	CcSEcCtD
Sulfadiazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000443	0.00165	CcSEcCtD
Sulfadiazine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000442	0.00165	CcSEcCtD
Sulfadiazine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00044	0.00164	CcSEcCtD
Sulfadiazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00044	0.00164	CcSEcCtD
Sulfadiazine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00044	0.00164	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000439	0.00164	CcSEcCtD
Sulfadiazine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000436	0.00163	CcSEcCtD
Sulfadiazine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000436	0.00163	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000435	0.00162	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000432	0.00161	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.00161	CcSEcCtD
Sulfadiazine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000431	0.00161	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000426	0.00159	CcSEcCtD
Sulfadiazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000424	0.00158	CcSEcCtD
Sulfadiazine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000424	0.00158	CcSEcCtD
Sulfadiazine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00157	CcSEcCtD
Sulfadiazine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000414	0.00155	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.00154	CcSEcCtD
Sulfadiazine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000412	0.00154	CcSEcCtD
Sulfadiazine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000411	0.00153	CcSEcCtD
Sulfadiazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.00153	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00153	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000395	0.00148	CcSEcCtD
Sulfadiazine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000394	0.00147	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.00145	CcSEcCtD
Sulfadiazine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000382	0.00143	CcSEcCtD
Sulfadiazine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00142	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000379	0.00141	CcSEcCtD
Sulfadiazine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000379	0.00141	CcSEcCtD
Sulfadiazine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000378	0.00141	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000375	0.0014	CcSEcCtD
Sulfadiazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000375	0.0014	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000375	0.0014	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000372	0.00139	CcSEcCtD
Sulfadiazine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000367	0.00137	CcSEcCtD
Sulfadiazine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000357	0.00133	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000357	0.00133	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000355	0.00133	CcSEcCtD
Sulfadiazine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.00132	CcSEcCtD
Sulfadiazine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00131	CcSEcCtD
Sulfadiazine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00131	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00131	CcSEcCtD
Sulfadiazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00035	0.0013	CcSEcCtD
Sulfadiazine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.0013	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00129	CcSEcCtD
Sulfadiazine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000345	0.00129	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.00129	CcSEcCtD
Sulfadiazine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000344	0.00128	CcSEcCtD
Sulfadiazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000344	0.00128	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00128	CcSEcCtD
Sulfadiazine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000341	0.00127	CcSEcCtD
Sulfadiazine—Rash—Vincristine—peripheral nervous system neoplasm	0.000338	0.00126	CcSEcCtD
Sulfadiazine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000338	0.00126	CcSEcCtD
Sulfadiazine—Headache—Vincristine—peripheral nervous system neoplasm	0.000336	0.00125	CcSEcCtD
Sulfadiazine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.00123	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00123	CcSEcCtD
Sulfadiazine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000325	0.00121	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00121	CcSEcCtD
Sulfadiazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00032	0.0012	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00032	0.00119	CcSEcCtD
Sulfadiazine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000319	0.00119	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.00118	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000308	0.00115	CcSEcCtD
Sulfadiazine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000308	0.00115	CcSEcCtD
Sulfadiazine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000302	0.00113	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.00112	CcSEcCtD
Sulfadiazine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000299	0.00112	CcSEcCtD
Sulfadiazine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000299	0.00112	CcSEcCtD
Sulfadiazine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000297	0.00111	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.0011	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00106	CcSEcCtD
Sulfadiazine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00105	CcSEcCtD
Sulfadiazine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000276	0.00103	CcSEcCtD
Sulfadiazine—Rash—Etoposide—peripheral nervous system neoplasm	0.000274	0.00102	CcSEcCtD
Sulfadiazine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000274	0.00102	CcSEcCtD
Sulfadiazine—Headache—Etoposide—peripheral nervous system neoplasm	0.000272	0.00102	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000268	0.001	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000997	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000965	CcSEcCtD
Sulfadiazine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000258	0.000964	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000949	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000926	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000923	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000909	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000893	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00089	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000878	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000867	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000841	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000828	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000824	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000822	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000802	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000212	0.00079	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000785	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000767	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000761	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000744	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000731	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000726	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000722	CcSEcCtD
Sulfadiazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000719	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000719	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000688	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00067	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000668	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000665	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000665	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000643	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000622	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00062	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000595	CcSEcCtD
Sulfadiazine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000578	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000576	CcSEcCtD
Sulfadiazine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000573	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000573	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00057	CcSEcCtD
Sulfadiazine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00054	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000535	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00053	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00053	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000527	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.0005	CcSEcCtD
